Net Income (Loss) Attributable to Parent in USD of NEVRO CORP from 2012 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Nevro Corp quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2012 to Q4 2024.
  • Nevro Corp Net Income (Loss) Attributable to Parent for the quarter ending 31 Dec 2024 was -$53.1M, a 491% decline year-over-year.
  • Nevro Corp Net Income (Loss) Attributable to Parent for the twelve months ending 31 Dec 2024 was -$113M, a 23% decline year-over-year.
  • Nevro Corp annual Net Income (Loss) Attributable to Parent for 2024 was -$113M, a 23% decline from 2023.
  • Nevro Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$92.2M, a 3173% decline from 2022.
  • Nevro Corp annual Net Income (Loss) Attributable to Parent for 2022 was $3M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

NEVRO CORP Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$113M -$53.1M -$44.1M -491% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025
Q3 2024 -$69.3M -$15.3M +$8.14M +34.6% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 -$77.4M -$19.6M +$5.15M +20.8% 01 Apr 2024 30 Jun 2024 10-Q 12 Nov 2024
Q1 2024 -$82.6M -$25.4M +$9.62M +27.5% 01 Jan 2024 31 Mar 2024 10-Q 12 Nov 2024
Q4 2023 -$92.2M -$8.98M +$10.2M +53.2% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025
Q3 2023 -$102M -$23.5M -$105M -129% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $2.56M -$24.7M +$266K +1.06% 01 Apr 2023 30 Jun 2023 10-Q 12 Nov 2024
Q1 2023 $2.3M -$35M -$704K -2.05% 01 Jan 2023 31 Mar 2023 10-Q 12 Nov 2024
Q4 2022 $3M -$19.2M +$10.9M +36.3% 01 Oct 2022 31 Dec 2022 10-K 04 Mar 2025
Q3 2022 -$7.94M $81.5M +$132M 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023
Q2 2022 -$140M -$25M -$3.4M -15.7% 01 Apr 2022 30 Jun 2022 10-Q 01 Nov 2023
Q1 2022 -$136M -$34.3M -$4.76M -16.1% 01 Jan 2022 31 Mar 2022 10-Q 01 Nov 2023
Q4 2021 -$131M -$30.1M -$23M -323% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2024
Q3 2021 -$108M -$50.1M -$40.1M -402% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 -$68.3M -$21.6M +$19.5M +47.4% 01 Apr 2021 30 Jun 2021 10-Q 02 Nov 2022
Q1 2021 -$87.7M -$29.6M -$4.67M -18.8% 01 Jan 2021 31 Mar 2021 10-Q 02 Nov 2022
Q4 2020 -$83.1M -$7.13M +$6.61M +48.1% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2021
Q3 2020 -$89.7M -$9.99M +$7.86M +44.1% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 -$97.5M -$41.1M -$13M -46.5% 01 Apr 2020 30 Jun 2020 10-Q 08 Nov 2021
Q1 2020 -$84.5M -$24.9M +$19.2M +43.5% 01 Jan 2020 31 Mar 2020 10-Q 08 Nov 2021
Q4 2019 -$104M -$13.7M -$4.14M -43% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2021
Q3 2019 -$99.6M -$17.8M -$6.58M -58.4% 01 Jul 2019 30 Sep 2019 10-K 24 Feb 2021
Q2 2019 -$93M -$28M -$17.4M -164% 01 Apr 2019 30 Jun 2019 10-K 24 Feb 2021
Q1 2019 -$75.6M -$44.1M -$26.4M -149% 01 Jan 2019 31 Mar 2019 10-K 24 Feb 2021
Q4 2018 -$49.2M -$9.61M -$5.3M -123% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2020
Q3 2018 -$43.9M -$11.3M -$5.04M -80.8% 01 Jul 2018 30 Sep 2018 10-K 25 Feb 2020
Q2 2018 -$38.9M -$10.6M +$990K +8.53% 01 Apr 2018 30 Jun 2018 10-K 25 Feb 2020
Q1 2018 -$39.9M -$17.7M -$3.21M -22.1% 01 Jan 2018 31 Mar 2018 10-K 25 Feb 2020
Q4 2017 -$36.7M -$4.31M +$5.51M +56.1% 01 Oct 2017 31 Dec 2017 10-K 21 Feb 2019
Q3 2017 -$42.2M -$6.23M -$2.34M -60.3% 01 Jul 2017 30 Sep 2017 10-K 21 Feb 2019
Q2 2017 -$39.8M -$11.6M -$2.83M -32.2% 01 Apr 2017 30 Jun 2017 10-K 21 Feb 2019
Q1 2017 -$37M -$14.5M -$5.22M -56.2% 01 Jan 2017 31 Mar 2017 10-K 21 Feb 2019
Q4 2016 -$31.8M -$9.83M +$4.37M +30.8% 01 Oct 2016 31 Dec 2016 10-K 22 Feb 2018
Q3 2016 -$36.1M -$3.89M +$15.6M +80% 01 Jul 2016 30 Sep 2016 10-K 22 Feb 2018
Q2 2016 -$51.7M -$8.78M +$10.9M +55.5% 01 Apr 2016 30 Jun 2016 10-K 22 Feb 2018
Q1 2016 -$62.7M -$9.29M +$4.77M +33.9% 01 Jan 2016 31 Mar 2016 10-K 22 Feb 2018
Q4 2015 -$67.4M -$14.2M -$5.88M -70.8% 01 Oct 2015 31 Dec 2015 10-K 23 Feb 2017
Q3 2015 -$61.6M -$19.5M -$11.6M -147% 01 Jul 2015 30 Sep 2015 10-K 23 Feb 2017
Q2 2015 -$50M -$19.7M -$12.3M -166% 01 Apr 2015 30 Jun 2015 10-K 23 Feb 2017
Q1 2015 -$37.7M -$14.1M -$7M -99.3% 01 Jan 2015 31 Mar 2015 10-K 23 Feb 2017
Q4 2014 -$30.7M -$8.31M -$1.57M -23.3% 01 Oct 2014 31 Dec 2014 10-K 29 Feb 2016
Q3 2014 -$29.1M -$7.89M -$2.87M -57.2% 01 Jul 2014 30 Sep 2014 10-K 29 Feb 2016
Q2 2014 -$26.2M -$7.43M -$540K -7.84% 01 Apr 2014 30 Jun 2014 10-K 29 Feb 2016
Q1 2014 -$25.7M -$7.06M +$313K +4.25% 01 Jan 2014 31 Mar 2014 10-K 29 Feb 2016
Q4 2013 -$26M -$6.74M 01 Oct 2013 31 Dec 2013 10-K 18 Mar 2015
Q3 2013 -$5.02M 01 Jul 2013 30 Sep 2013 10-K 18 Mar 2015
Q2 2013 -$6.89M 01 Apr 2013 30 Jun 2013 10-K 18 Mar 2015
Q1 2013 -$7.37M 01 Jan 2013 31 Mar 2013 10-K 18 Mar 2015

NEVRO CORP Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$113M -$21.2M -23% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025
2023 -$92.2M -$95.2M -3173% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025
2022 $3M +$134M 01 Jan 2022 31 Dec 2022 10-K 04 Mar 2025
2021 -$131M -$48.3M -58.1% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024
2020 -$83.1M +$20.6M +19.9% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023
2019 -$104M -$54.5M -111% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022
2018 -$49.2M -$12.5M -34.2% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021
2017 -$36.7M -$4.88M -15.4% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020
2016 -$31.8M +$35.7M +52.9% 01 Jan 2016 31 Dec 2016 10-K 21 Feb 2019
2015 -$67.4M -$36.8M -120% 01 Jan 2015 31 Dec 2015 10-K 22 Feb 2018
2014 -$30.7M -$4.67M -17.9% 01 Jan 2014 31 Dec 2014 10-K 23 Feb 2017
2013 -$26M -$7.05M -37.2% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 -$19M 01 Jan 2012 31 Dec 2012 10-K 18 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.